Accordingly, we hypothesized that increased adiponectin secretion is a major compensatory mechanism that attempts to prevent the onset of glucose metabolism disorders after a Th1/Th2 ratio disorder caused by low-grade inflammation. The gene discussed is ADIPOQ; the disease is glucose metabolism disease.